Bedaquiline fumarate is a fumarate salt formed from bedaquiline and fumaric acid, used as an active pharmaceutical ingredient in combination therapy for pulmonary multi-drug resistant tuberculosis. It acts by inhibiting ATP synthase, an enzyme essential for mycobacterial replication.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Bedaquiline fumarate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Bedaquiline
pharmaceutical raw material
Boldenone
pharmaceutical raw material
Lorazepam
pharmaceutical raw material
Temazepam
pharmaceutical raw material
Erdosteine
pharmaceutical raw material
(1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol;(E)-but-2-enedioic acid
ZLVSPMRFRHMMOY-WWCCMVHESA-N
CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O.C(=C/C(=O)O)\C(=O)O
Sourcing Bedaquiline fumarate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.